GLP-1 medications are making headlines in medical weight loss—learn how they impact overall health and chronic disease ...
GLP-1 agonists may be protective against hip fracture when administered for the treatment of type 2 diabetes, according to ...
Glucagon-like peptide 1 receptor agonists appear to reduce the risk of age-related macular degeneration and primary open-angle glaucoma.
The FDA says state-licensed compounding pharmacies must immediately stop making compound versions of GLP-1 drugs. Larger, national licensed facilities making compound versions of Zepbound have until ...
The risk for moderate or severe COPD exacerbation was lower among those treated with SGLT-2is and with GLP-1 RAs versus DPP-4is.
With respect to risks, GLP-1RA use was significantly associated with an increased risk of gastrointestinal disorders, hypotension, syncope, arthritic disorders, drug-induced pancreatitis, and other ...
Las inyecciones 'milagro' contra la obesidad sólo sirven si desarrollamos hábitos de vida saludable mientras las estamos ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback